
Fujifilm has announced it is investing $2 billion to establish a new large-scale cell culture production site in the US. …

The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …

In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …

The WHO has recommended against the UK’s plans to delay second doses of the COVID-19 vaccine by 12 weeks, saying …

The European Commission has approved Biogen’s Plegridy (peginterferon beta-1a), a new intramuscular (IM) injection for the treatment of relapsing-remitting multiple …

Angelini Pharma is set to acquire Arvelle Therapeutics, a biopharmaceutical company focused on bringing innovative treatments to patients suffering from …

AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney …

Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.

PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as …

Biopharmaceutical group Sosei Heptares has announced it is to regain the worldwide rights to its muscarinic agonist programmes, after they …

Moderna has announced that Israel’s Ministry of Health (MOH) has authorised the use of its COVID-19 vaccine. Israel has secured …

Genentech has announced that tiragolumab, a novel cancer immunotherapy designed to bind to T cell immunoreceptor with Ig and ITIM …

Emergex, a company focusing on the development of medicines against viral and bacterial infectious diseases, has announced a collaboration and …

In a study funded by Cancer Research UK and Wellcome, scientists have developed a new drug that effectively targets the …

Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …

Experts have expressed concern over India’s emergency approval of its homegrown COVID-19 vaccine, Covaxin, before studies have been completed. The …

Moderna’s COVID-19 vaccine has achieved over 90% efficacy in interim safety and primary efficacy results following its Phase III trial. …

RedHill Biopharma has announced that preliminary top-line data from its US Phase II study with orally-administered opaganib (Yeliva) in patients …

The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …

The COVID-19 pandemic has, unsurprisingly, dominated the news this year. The site’s most popular articles of 2020, focused largely on …